Synthetic peptide, corresponding to a region within amino acids 1525-1575 of Human DENND4A (NP_005839.3).
Jurkat, 293T and HeLa whole cell lysates.
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Constituents: 99% Tris citrate/phosphate, 0.09% Sodium chloride
Note: pH 7 to 8
Concentration information loading...
Immunogen affinity purified
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
1/1000 - 1/5000. Predicted molecular weight: 209 kDa.
Is unsuitable for IP.
Binds to ISRE-like element (interferon-stimulated response element) of MYC P2 promoter.
Expressed ubiquitously. Highest expression in bone marrow, medium in peripheral blood lymphocytes and lowest in spleen. In brain, breast, and prostate, higher expression was seen in normal cells than in tumor cells. Expression is regulated in a growth- and cell cycle-dependent manner.
Contains 1 dDENN domain.
Contains 1 DENN domain. Contains 1 MABP domain. Contains 2 PPR (pentatricopeptide) repeats. Contains 1 uDENN domain.
Highly expressed in fetal liver.
Information by UniProt
C-myc promoter-binding protein antibody
DENN domain-containing protein 4A antibody
DENN/MADD domain containing 4A antibody
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"